Research ELISA (Enzyme-Linked Immunosorbent Assay) - Global Strategic Business Report

The global market for Research ELISA (Enzyme-Linked Immunosorbent Assay) is estimated at US$538.2 Million in 2023 and is projected to reach US$692.3 Million by 2030, growing at a CAGR of 3.7% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

The growth in the ELISA market is driven by several factors including advancements in technology, increasing prevalence of chronic and infectious diseases, and the rising demand for cost-effective and reliable diagnostic methods. Technological innovations, such as the development of automated and high-throughput ELISA systems, have significantly improved the efficiency and accuracy of the assays. The surge in chronic diseases like cancer and diabetes, alongside emerging infectious diseases, has amplified the need for precise diagnostic tools, thus boosting the demand for ELISA. Additionally, the growing trend towards personalized medicine and the expanding application of ELISA in drug development and monitoring therapeutic responses have further fueled market growth. The increasing awareness and regulatory emphasis on food and environmental safety also contribute to the expanding ELISA market, as these assays are vital for ensuring compliance with safety standards.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the ELISA Kits segment, which is expected to reach US$478.6 Million by 2030 with a CAGR of a 3.5%. The ELISA Development Sets & Antibody Pairs segment is also set to grow at 4.1% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, estimated at $145.6 Million in 2023, and China, forecasted to grow at an impressive 6.1% CAGR to reach $140.2 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Research ELISA (Enzyme-Linked Immunosorbent Assay) Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Research ELISA (Enzyme-Linked Immunosorbent Assay) Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Research ELISA (Enzyme-Linked Immunosorbent Assay) Market expected to evolve by 2030?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2030?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of major players such as American Laboratory Products Company (ALPCO) (US), BD Biosciences (US), BioLegend, Inc. (US), and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 27 Featured):

• American Laboratory Products Company (ALPCO) (US)
• BD Biosciences (US)
• BioLegend, Inc. (US)
• Bio-Rad Laboratories, Inc. (US)
• Enzo Life Sciences, Inc. (US)
• Merck KGaA
• Mercodia AB (Sweden)
• R&D Systems, Inc. (US)
• Thermo Fischer Scientific Inc.